Reduced hepatic drug-metabolising enzyme activities in spontaneously hyperlipidaemic rat as an animal model of hypercholesterolaemia

Medical Science Research

Volumn 24, Issue 4, 1996, Pages 257-259

  Watanabe, Minoru ^a   Nakura, Hironori ^a   Tateishi, Tomonori ^a   Tanaka, Masami ^a   Kumai, Toshio ^a   Kobayashi, Shinichi ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cholesterol; Drug metabolising enzymes; Estradiol; Hypercholesterolaemia; Spontaneously hyperlipidaemic rat; Testosterone

Indexed keywords

AMINOPYRINE N DEMETHYLASE; CHOLESTEROL; DRUG METABOLIZING ENZYME; ESTRADIOL; GLUCURONOSYLTRANSFERASE; LIPID; SEX HORMONE; TESTOSTERONE; TRIACYLGLYCEROL; UNSPECIFIC MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; ESTRADIOL BLOOD LEVEL; FEMALE; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; MALE; NONHUMAN; RAT; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALIA;

EID: 0029933052     PISSN: 02698951     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Benfante, R. and Reed, D. 1990. J.M.M.A., 263, 393-396
2. Castelli, W.P., Wilson, P.W.F., Levy, D. et al. 1989. Am. J. Cardiol., 63, 12H-19H
3. Adult Treatment Panel II 1993. J.M.M.A., 269, 3015-3023
4. Howard, B.V., Savage, P.J., Bennion, LJ. and Bennett, P.M. 1978. Atheroscelerosis,3Q, 153-162
5. Zaleski, J., Kwei, G.Y., Thurman, R.G. and Kauffman, F.C. 1991 Carcinogenesis, 12, 2073-2079
6. Facino, R.M., Carini, M, Tofanetti, O. et al. 1987. Arzneim.Forsch./Drug Res., 37, 682-691
7. Chu, I., Villeneuve, D.C., Secours, V. E. et al. 1986. Fundam. Appl. Toxicol., 69-77
8. Kato, N. Mochizuki, S., Kawai, K. and Yoshida, A. 1982. J. Nutr., 112, 848-854
9. Bursain, S.J., Polin, D., Oison, B.A. et al. 1983. J. Toxicol Environ. Health., 12 291-307
10. Tanaka, M., Matsumoto, C, Kumai, T. et al. 1994. St. Marianna Med. J., 22, 261-268
11. Hirai, M., Masubuchi, Y., Kumai, T. et al. 1981. Folia Pharmacol. Japon., 77, 261-272
12. Omuru, T. and Sato, R. 1964. J. Biol. Chem., 239, 2370-2378
13. Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J., 1951. J. Biol. Chem., 193, 265-275
14. Schenkman, J.B., Remmer, H. and Estabrook, R.W. 1967. Mol. Pharmacol., 3, 113-123
15. Nash, T. 1953. Biochem J., 55, 416-421.
16. Habig, W.T., Pabst, M.J. and Jakoby, W.B. 1974. J. Biol Chem., 249, 7130-7139
17. Burchell, B. and Weatheril, P. 1981. Neth. Enzymol., 77, 169-177
18. Cashman, J.R. and Hanzlik, R.P. 1981. Biochem. Biophys. Res. Commun., 98, 147-153
19. Nebert, D.W. 1978. Meth Enzymol, 52, 226-240
20. Andres, H.H., Klem, A.J., Szabo, S.M. and Weber, W.W. 1985. Anal. Biochem., 145, 367-375
21. Reichen, J., Euters, J.T., Sojic, Z. and Roos, F.J. 1992. Experientia, 48, 48286
22. Kremers, P., Beaune, P., Cresteil, T. et al, 1981. Eur. J. Biochem., 118, 599-606
23. Kamataki, T., Maeda, K., Shimada, M. et al, 1985. J. Pharmacol. Exp. Ther., 233, 222-233
24. Dannan, G.A. and Guengerich, P.P., 1982. Mol. Pharmacol., 22, 787-794
25. Inscoe, J.K. and Axelrod, J. 1960. J. Pharmacol. Exp. Ther., 129, 128-131
26. Kato, R. and Onoda, K. 1966. Jap. J. Pharmacol., 16, 217-219
27. Fujita, S., Chiba, M., Ohta, M. et al. 1990. J. Pharmacol. Exp. Ther., 253. 369-374
28. Kato, R. and Gillette, J.R. 1965. J. Pharmacol. Exp. Ther., 150, 279-284
29. Bandiera, S., and Dworschak, C. 1992. Arch. Biochem. Biophys., 296, 286-295
30. Robl, J.M., Thomford, P.J., Wu, M.C. and Dziuk, P.J. 1985. Pediatr. Pharmacol., B, 157-164
31. Kato, R. and Onoda, K. 1970. Biochem Pharmacol, 19, 1649-1660
32. Lee, M.Y., Clark, J.E. and Williams, D.E. 1993. Arch Biochem. Biophys., 302, 332-336
33. Semenkovich, C.F. and Ostlund, R.E. 1987. Biochemistry, 26, 4987-4992